Bellerophon Therapeutics Announces FDA Clears Initiation of Phase 3 Study for INOpulse Inhaled…
Bellerophon Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) accepted its Investigational New Drug (IND) application, allowing the Company to initiate a…
Read More...
Read More...
